← All trials
NCT05595447
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 18, 2022
- Primary completion
- Oct 18, 2024
- Completion date
- Oct 18, 2024
- First posted
- Oct 27, 2022
- Last posted
- Oct 27, 2022
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hospital Regional Alta Especialidad BajioLead sponsor
- Hospital Regional Alta Especialidad BajioReponsible party - principal investigator
- Universidad de GuanajuatoCollaborator
- Hospital Regional Alta Especialidad BajioSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.